Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D, Genetics, and Neuroimaging in Cerebral Small Vessel Disease
ChiCTR2300068710Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vitamin d in Cerebral Small Vessel Disease (CSVD) (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Neuropsychological assessment. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
vitamin d
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on ChiCTR2300068710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068710.